U.S. healthcare stocks had a strong 2018, rising 4.7 percent overall, and experts say they should continue to do well in the new year.

Copayment vouchers for P2Y12 inhibitors modestly improved the likelihood that patients would continue taking the guideline-recommended medications for one year after myocardial infarction, according to a study published in JAMA. However, patients supplied with this financial assistance didn’t see a subsequent improvement in clinical outcomes.

ST-segment elevation myocardial infarction (STEMI) survivors covered by Medicaid have lower rates of revascularization and higher rates of in-hospital mortality than their counterparts with private insurance, according to a study published in Circulation: Cardiovascular Quality and Outcomes.

Change Healthcare and Health Fidelity are partnering to offer a risk adjustment coding solution that uses natural language processing (NLP) and machine learning to increase claim accuracy and address compliance issues, the companies announced Monday, Jan. 14.

High retail prices for diabetes test strips are driving a “gray market” in the U.S. as an increasing number of uninsured diabetics struggle to afford something they need as often as 10 times a day, the New York Times reports.

Carestream has announced that it was granted 42 new patents from the U.S. Patent and Trademark Office in 2018. The patents were focused on digital radiography, extremity CT imaging and other key healthcare technologies. 

Ping An Insurance Company of China’s corporate venture fund is investing in AI medical solution company Airdoc, the company announced on Saturday, Jan. 12.

On Jan. 1, U.S. hospitals began posting prices online for all services offered, including medical imaging, in compliance with a new Trump administration order intended to increase transparency for health care consumers. However, according to a recent article from The New York Times, the policy change is "turning into a fiasco.”